Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002226133 | SCV002504514 | likely benign | not provided | 2019-04-29 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Labcorp Genetics |
RCV002226133 | SCV003453667 | benign | not provided | 2023-04-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV002226133 | SCV004564194 | likely benign | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004047229 | SCV004873349 | likely benign | Maturity onset diabetes mellitus in young | 2023-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003903621 | SCV004724661 | likely benign | GCK-related disorder | 2019-03-04 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |